N-Ethylhexedrone

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcCharacterization of neurotransmitter inhibition for seven cathinones by a proprietary fluorescent dye method.
3. 2026-09-24srcDesigner drugs: mechanism of action and adverse effects
4. 2026-09-24srcFatal intoxication with U-47700 in combination with other NPS (N-ethylhexedrone, adinazolam, 4-CIC, 4-CMC) confirmed by identification and quantification in autopsy specimens and evidences.
5. 2026-09-24srcDesigner Cathinones N-Ethylhexedrone and Buphedrone Show Different In Vitro Neurotoxicity and Mice Behaviour Impairment
6. 2026-09-24srcSevere Toxicity to the New Psychoactive Substances 3-Hydroxyphencyclidine and N-Ethylhexedrone: an Analytically Confirmed Case Report
7. 2026-09-24srcMetabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS/MS
8. 2026-09-24srcFatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption
9. 2026-09-24srcMetabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS.
10. 2026-09-24srcRepeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice
11. 2026-09-24srcStructure-Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the alpha-Carbon Side-Chain Length
12. 2026-09-24srcStructure-Activity Relationships for a Recently Controlled Synthetic Cathinone Dopamine Transporter Reuptake Inhibitor: α-Pyrrolidinohexiophenone (α-PHP)
13. 2026-09-24srcFatal N-Ethylhexedrone Intoxication
14. 2026-09-24srcN-Ethylhexedrone: A very long and bad trip! A case series
15. 2026-09-24srcSynthetic Cathinones and Their Potential Interactions with Prescription Drugs.
16. 2026-09-24srcA Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020
17. 2026-09-24srcBehavioral effects of four novel synthetic cathinone analogs in rodents
18. 2026-09-24srcRetrospective identification of new psychoactive substances in patient samples submitted for clinical drug analysis
19. 2026-09-24srcSynthetic Cathinones and Neurotoxicity Risks: A Systematic Review
20. 2026-09-24srcSynthetic Cathinones: Recent Developments, Enantioselectivity Studies and Enantioseparation Methods
21. 2026-09-24srcAcute Pharmacological Effects of Two Synthetic Cathinones in Humans: N-Ethylhexedrone and N-Ethyl-nor-pentedrone
22. 2026-09-24srcSchedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone [et al.] in Schedule I
23. 2026-09-24srcN-Ethylhexedrone
24. 2026-09-24srcCritical Review Report: N-Ethylhexedrone — WHO Expert Committee on Drug Dependence (47th ECDD)
25. 2026-09-24srcN-Ethylhexedrone — PubChem CID 134822125
26. 2026-09-04issueIssued emergency
27. 2026-09-04issueIssued info_card
28. 2026-09-04issueIssued notice
29. 2026-06-04proposal43 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
30. 2026-06-04publicationPublication — backfill
31. 2026-05-12revisionRevision 1
32. 2026-05-12absenceSearched ClinicalTrials.gov for "N-Ethylhexedrone" — no results
33. 2026-05-12genGeneration — pipeline-v5 · with 3 morepipeline-v5
34. 2026-05-12rungeneration run

The same entries, as forms: six forms.